Q2 2024 Holdings
Filed 2024-08-14 | 98 holdings | $867.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $190.5M | 350,000 | 22.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $38.8M | 994,227 | 4.5% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $32.9M | 836,283 | 3.8% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $30.8M | 110,000 | 3.6% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $25.4M | 460,000 | 2.9% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $23.6M | 1,450,000 | 2.7% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $23.1M | 515,000 | 2.7% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $20.4M | 500,000 | 2.4% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $19.0M | 912,000 | 2.2% |
| Teva Pharmaceutical Inds LTD(TEVA)Call | SPONSORED ADS | 881624209 | $18.7M | 1,150,000 | 2.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $17.6M | 475,400 | 2.0% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $17.3M | $17,000,000 | 2.0% |
| Alnylam Pharmaceuticals Inc | NOTE 1.000% 9/1 | 02043QAB3 | $16.2M | $15,000,000 | 1.9% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $15.7M | 110,000 | 1.8% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $15.7M | 650,000 | 1.8% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $15.2M | 200,000 | 1.7% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $15.0M | 4,300,000 | 1.7% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $13.6M | 375,000 | 1.6% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $13.4M | 650,000 | 1.5% |
| Inozyme Pharma Inc | COM | 45790W108 | $12.7M | 2,856,252 | 1.5% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $12.1M | 513,420 | 1.4% |
| Eliem Therapeutics Inc(CLYM) | COM | 28658R106 | $11.9M | 1,670,661 | 1.4% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $10.3M | 1,135,702 | 1.2% |
| Cerevel Therapeutics Hldng I(CERE1EUR)Call | COM | 15678U128 | $10.2M | 250,000 | 1.2% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $10.2M | 223,407 | 1.2% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $10.1M | 700,000 | 1.2% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $9.6M | 200,000 | 1.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $9.1M | 346,088 | 1.1% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $8.9M | 975,606 | 1.0% |
| Coherus Biosciences Inc | NOTE 1.500% 4/1 | 19249HAB9 | $8.6M | $11,750,000 | 1.0% |
| Morphic Hldg Inc | COM | 61775R105 | $8.5M | 250,573 | 1.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $8.4M | 125,000 | 1.0% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $8.1M | 423,155 | 0.9% |
| Omeros Corp | NOTE 5.250% 2/1 | 682143AG7 | $8.1M | $11,450,000 | 0.9% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $8.0M | 1,850,000 | 0.9% |
| Merus N V | COM | N5749R100 | $7.4M | 125,000 | 0.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $6.4M | 80,000 | 0.7% |
| Geron Corp(GERN) | COM | 374163103 | $6.4M | 1,500,000 | 0.7% |
| Karyopharm Therapeutics Inc | NOTE 3.000%10/1 | 48576UAA4 | $6.3M | $9,750,000 | 0.7% |
| Savara Inc(SVRA) | COM | 805111101 | $6.2M | 1,546,850 | 0.7% |
| Erasca Inc(ERAS) | COM | 29479A108 | $5.9M | 2,499,431 | 0.7% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $5.5M | 550,000 | 0.6% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $5.3M | 155,000 | 0.6% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $4.6M | 263,817 | 0.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $4.5M | 60,000 | 0.5% |
| Elevation Oncology Inc | COM | 28623U101 | $4.0M | 1,468,825 | 0.5% |
| Hillevax Inc | COM | 43157M102 | $3.8M | 265,859 | 0.4% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $3.8M | 327,959 | 0.4% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $3.7M | 351,587 | 0.4% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $3.5M | 100,000 | 0.4% |